Peripheral Nervous System Diseases: all 1,006 studies

Page 9 of 11. Open to participants first (178), then studies with results posted, then the rest; newest registration first within each.

• Vit D3 and Omega 3 in Chemo Induced NeuropathyStatus unknownNCT02294149Phase 3
• Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy ManagementTerminatedNCT02271893Phase 2
• Probing the Role of Sodium Channels in Painful NeuropathiesStatus unknownNCT02243475
• Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesActive, not recruitingNCT02221700Not applicable
• The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal RegenerationCompletedNCT02218866
• Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic PainCompletedNCT02217267Phase 3
• L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast CancerWithdrawnNCT02215083Phase 1
• Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)CompletedNCT02194010
• SINF: Peripheral Neuropathy in Cancer SurvivorsWithdrawnNCT02168894Phase 1/2
• Assessment of Neuropathic PainCompletedNCT02138344
• The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral NeuropathyCompletedNCT02127762Not applicable
• Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral NeuropathyCompletedNCT02115932Not applicable
• A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral PolyneuropathyCompletedNCT02107469Not applicable
• Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by ChemotherapyStatus unknownNCT02107417Not applicable
• Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)CompletedNCT02104466Not applicable
• Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral NeuropathyStatus unknownNCT02093910Phase 2
• Electrical Stimulation and Chemotherapy Induced Peripheral NeuropathyStatus unknownNCT02088996Not applicable
• A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its SafetyCompletedNCT02065349Phase 2
• The Effect of α-lipoic Acid Treatment in Patient With Cardiac Autonomic NeuropathyCompletedNCT02056366Phase 4
• A Study of Xuebi Formula for Diabetic Peripheral Neuropathy(Qi-deficiency and Blood-stasis)Status unknownNCT02039544Not applicable
• Effectiveness of Controlled-perturbation Gait Training on Gait Rehabilitation and Fear of Falling in Individuals With Gait ImpairmentsStatus unknownNCT02031757Not applicable
• The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral NeuropathyStatus unknownNCT02024191Phase 3
• The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)Status unknownNCT01990092Not applicable
• Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyCompletedNCT01982591
• Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory NeuropathyWithdrawnNCT01980368Not applicable
• The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg PainCompletedNCT01954199Not applicable
• A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)CompletedNCT01953757Not applicable
• Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber NeuropathyCompletedNCT01911975Phase 3
• Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial.CompletedNCT01895621Phase 4
• Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral NeuropathyCompletedNCT01893125Phase 2
• Acupuncture for Chemotherapy-induced Peripheral NeuropathyStatus unknownNCT01892852Not applicable
• Magnetic Resonance Diagnostics of Diabetic Peripheral NeuropathyCompletedNCT01847937
• Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.CompletedNCT01827072Phase 3
• Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRGTerminatedNCT01815346Phase 1/2
• Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral NeuropathyWithdrawnNCT01793350Phase 1/2
• Effect of EECP on Anterior Ischemic Optic NeuropathyStatus unknownNCT01768260Not applicable
• Exercise Capability and Training Effects in Diabetic Patients With NeuropathyCompletedNCT01760707Not applicable
• Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1ACompletedNCT01750710
• A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).CompletedNCT01726413Phase 2
• The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic NeuropathyStatus unknownNCT01706289
• Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma PatientsCompletedNCT01697839
• In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral NeuropathyCompletedNCT01695629
• A Nutritional Intervention for Diabetic NeuropathyCompletedNCT01690962Not applicable
• Calcium and Magnesium Infusion for the Prevention of Taxane Induced NeuropathyCompletedNCT01682499Phase 1
• Safety and Efficacy of CBX129801 in Patients With Type 1 DiabetesCompletedNCT01681290Phase 2
• Acupuncture for Peripheral NeuropathyTerminatedNCT01633281Phase 2
• Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic NeuropathyCompletedNCT01628627Phase 4
• MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic PainTerminatedNCT01620775Not applicable
• Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%WithdrawnNCT01607671Phase 1
• A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral NeuropathyCompletedNCT01589432Phase 2
• Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral NeuropathyCompletedNCT01569269Not applicable
• Characterization and Treatment of Chemotherapy NeuropathyCompletedNCT01557608Not applicable
• A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral NeuropathyStatus unknownNCT01537705Phase 2
• Biomarker for Metachromatic Leukodystrophy (BioMeta) DiseaseWithdrawnNCT01536327
• Clinical Study on Acetyl-L-CarnitineCompletedNCT01526564Phase 3
• Nutritional Supplementation With Agmatine Sulfate During Small Fiber NeuropathyStatus unknownNCT01524666
• Vitamin E for Oxaliplatin-induced Peripheral Neuropathy ProphylaxisCompletedNCT01523574Phase 2
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral NeuropathyCompletedNCT01521598Phase 2
• Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective StudyCompletedNCT01512030
• Metanx Effects on Nerve Fiber Density in Neuropathic DiabeticsStatus unknownNCT01503892Not applicable
• Giant Axonal Neuropathy Natural History StudyTerminatedNCT01503125
• Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyWithdrawnNCT01492920Phase 3
• A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic PatientsCompletedNCT01478607Phase 3
• Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral NeuropathyCompletedNCT01469559Phase 2
• Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet StudyCompletedNCT01465620Phase 3
• Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced NeuropathyCompletedNCT01422993Not applicable
• Neuromuscular Ultrasound for Focal NeuropathiesCompletedNCT01394822
• Intrathecal Bolus Doses of ZiconotideCompletedNCT01373983Phase 4
• Metanx® P.L.U.S. Program (Progress Through Learning, Understanding & Support)Status unknownNCT01368549
• Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With ChemotherapyCompletedNCT01347723
• Optic Neuropathy in 10 Patients With Glioblastoma Receiving BevacizumabWithdrawnNCT01331616Early Phase 1
• Complementary and Integrative Therapy for Diabetic NeuropathyCompletedNCT01296308
• Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND StudyTerminatedNCT01280747
• Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT01278225
• Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)CompletedNCT01278004Phase 2
• Can Ultrasound Detect Diabetic Peripheral Neuropathy?CompletedNCT01261442
• Administrative Claims Analysis of Metanx® in Diabetic Peripheral NeuropathyCompletedNCT01247558
• Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelTerminatedNCT01243541Not applicable
• Sensory Reeducation in Peripheral Nerve Injuries of HandCompletedNCT01215760Not applicable
• Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral NeuropathyStatus unknownNCT01214590Not applicable
• Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)CompletedNCT01192113Phase 4
• Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral NeuropathyStatus unknownNCT01175928Phase 1/2
• The Pathophysiology of Bortezomib Induced Peripheral NeuropathyStatus unknownNCT01171443
• Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative StudyCompletedNCT01160887
• Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful NeuropathyCompletedNCT01135251Phase 2
• Capsaicin Nanoparticle in Patient With Painful Diabetic NeuropathyStatus unknownNCT01125215Phase 2/3
• Small-fiber Neuropathy in Chronic Kidney DiseaseStatus unknownNCT01078857Not applicable
• Fall Risk Assessment in People With Diabetic NeuropathyCompletedNCT01040962
• Chemotherapy-Induced Peripheral Neuropathy SurveyWithdrawnNCT01016028
• Treatment Trial Using Low Level Laser Therapy (LLLT) for Treatment of Chemotherapy Induced Peripheral NeuropathyCompletedNCT01006408Not applicable
• Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?CompletedNCT01002053
• A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful NeuropathyTerminatedNCT00993018Phase 2
• Effects of Meditation on Multiple Sclerosis and Peripheral NeuropathyCompletedNCT00981643Not applicable
• Skin Biopsies in Chemotherapy-Induced NeuropathyCompletedNCT00956033
• The Relative Prevalence and Severity of Autonomic Nervous System DysfunctionCompletedNCT00919347
• A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain ConditionsCompletedNCT00904202Phase 4
• Role of Indicator Test (Neuropad) in Detecting Diabetic NeuropathyCompletedNCT00895440
• Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral NeuropathyCompletedNCT00891683Phase 2
• The Evaluation of Safety and Efficacy of JWHGWT on Diabetic NeuropathyStatus unknownNCT00886665Phase 3
• Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral NeuropathyCompletedNCT00876538Phase 2

← Peripheral Nervous System Diseases overview